# A Study to Evaluate the Pharmacokinetics of PEP005 (Ingenol Mebutate) Gel, 0.05%, When Applied in a Maximal Use Setting to the Dorsal Aspect of the Forearm in Patients With Actinic Keratosis

> **NCT00852137** · PHASE2 · COMPLETED · sponsor: **Peplin** · enrollment: 16 (actual)

## Conditions studied

- Actinic Keratosis

## Interventions

- **DRUG:** PEP005 (ingenol mebutate) Gel, 0.05%
- **DRUG:** Vehicle Gel

## Key facts

- **NCT ID:** NCT00852137
- **Lead sponsor:** Peplin
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2009-06
- **Final completion:** 2009-06
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2015-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00852137

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00852137, "A Study to Evaluate the Pharmacokinetics of PEP005 (Ingenol Mebutate) Gel, 0.05%, When Applied in a Maximal Use Setting to the Dorsal Aspect of the Forearm in Patients With Actinic Keratosis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00852137. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*